Clostridium difficile: Deleterious Impact on Hematopoietic Stem Cell Transplantation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clostridium difficile: Deleterious Impact on Hematopoietic Stem Cell Transplantation
Authors
Keywords
<em class=EmphasisTypeItalic >C. difficile</em>, C difficile infection, CDI, Clostridium difficile-associated disease, Diarrhea, Hematopoietic stem cell transplant, Hematologic malignancies, Immunosuppressed, Epidemiology, Diagnosis, Treatment, Outcomes
Journal
Current Hematologic Malignancy Reports
Volume 9, Issue 1, Pages 85-90
Publisher
Springer Nature
Online
2014-01-04
DOI
10.1007/s11899-013-0193-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fidaxomicin versus Conventional Antimicrobial Therapy in 59 Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation with Clostridium difficile-Associated Diarrhea
- (2013) Dana S. Clutter et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clostridium difficile Infection after Adult Autologous Stem Cell Transplantation: A Multicenter Study of Epidemiology and Risk Factors
- (2013) Carolyn D. Alonso et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Resolution of Clostridium difficile–Associated Diarrhea in Patients With Cancer Treated With Fidaxomicin or Vancomycin
- (2013) Oliver A. Cornely et al. JOURNAL OF CLINICAL ONCOLOGY
- Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection
- (2013) Timothy D Planche et al. LANCET INFECTIOUS DISEASES
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clostridium difficile Infection after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, and Outcome
- (2012) Lise Willems et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Changing Epidemiology of Clostridium difficile–Associated Disease during Stem Cell Transplantation
- (2012) Steven M. Trifilio et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of -defensins
- (2012) Y. Eriguchi et al. BLOOD
- Epidemiology and Outcomes of Clostridium difficile Infections in Hematopoietic Stem Cell Transplant Recipients
- (2012) C. D. Alonso et al. CLINICAL INFECTIOUS DISEASES
- Current Status of Clostridium difficile Infection Epidemiology
- (2012) F. C. Lessa et al. CLINICAL INFECTIOUS DISEASES
- Hospital-Onset Clostridium difficile Infection Rates in Persons with Cancer or Hematopoietic Stem Cell Transplant: A C3IC Network Report
- (2012) Mini Kamboj et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Fecal microbiota transplantation for fulminantClostridium difficileinfection in an allogeneic stem cell transplant patient
- (2012) K. Neemann et al. Transplant Infectious Disease
- Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections
- (2011) Kathleen M. Mullane et al. CLINICAL INFECTIOUS DISEASES
- Fidaxomicin versus Vancomycin forClostridium difficileInfection
- (2011) Thomas J. Louie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation
- (2010) Teena Chopra et al. CLINICAL TRANSPLANTATION
- Incidence of Clostridium difficile Infection in Patients with Acute Leukemia and Lymphoma after Allogeneic Hematopoietic Stem Cell Transplantation
- (2010) Sharon Leung et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
- (2010) Stuart H. Cohen et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Evaluation of the Cepheid XpertClostridium difficileEpi Assay for Diagnosis ofClostridium difficileInfection and Typing of the NAP1 Strain at a Cancer Hospital
- (2010) N. Esther Babady et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation
- (2009) K A Guthrie et al. BONE MARROW TRANSPLANTATION
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI)
- (2009) M.P. Bauer et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes
- (2009) Erik R. Dubberke et al. CLINICAL TRANSPLANTATION
- Short- and Long-Term Attributable Costs of Clostridium difficile-Associated Disease in Nonsurgical Inpatients
- (2008) E. R. Dubberke et al. CLINICAL INFECTIOUS DISEASES
- Infection control measures to limit the spread of Clostridium difficile
- (2008) R.-P. Vonberg et al. CLINICAL MICROBIOLOGY AND INFECTION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started